Intravenous Therapy Solutions Market Report 2026

Intravenous Therapy Solutions Market Overview

• Intravenous Therapy Solutions market size has reached to $13.17 billion in 2025 • Expected to grow to $21.25 billion in 2030 at a compound annual growth rate (CAGR) of 10% • Growth Driver: Growing Demand For Minimally Invasive Therapies Driving The Market Growth Due To Increasing Preference For Faster Recovery And Reduced Postoperative Pain • Market Trend: Standardized IV Solutions Gaining Momentum In Clinical Practice • North America was the largest region in 2025.

What Is Covered Under Intravenous Therapy Solutions Market?

Intravenous therapy solutions refer to sterile liquid formulations that are administered directly into a patient’s vein to deliver fluids, medications, nutrients, or electrolytes. These solutions treat dehydration, electrolyte imbalances, infections, and provide essential nutrients when oral intake is not possible. They are commonly composed of water, salts, sugars, or medicinal compounds and are tailored based on patient needs and medical conditions. The main product types of intravenous therapy solutions are crystalloids, colloids, blood products, and others. Crystalloids are intravenous fluids composed of water and electrolytes, used to quickly restore hydration and fluid balance in medical emergencies. These solutions are used for various applications such as fluid and electrolyte imbalance, nutritional support, medication administration, blood transfusion, and others. They are provided across various end users, including hospitals, clinics, ambulatory surgical centers, home care settings, and others.

What Is The Intravenous Therapy Solutions Market Growth Forecast?

The intravenous therapy solutions market size is expected to see strong growth in the next few years. It will grow to $21.25 billion in 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to increasing home healthcare adoption, rising demand for personalized nutrition and medication administration, technological integration with digital health platforms, expansion in emerging markets, growth in chronic disease management. Major trends in the forecast period include personalized iv therapy solutions, portable and home-based iv devices, infection control and safety enhancements, advanced electrolyte and nutrient formulations, integration with electronic health records (ehr).

Global Intravenous Therapy Solutions Market Segmentation

1) By Product Type: Crystalloids, Colloids, Blood Products, Other Product Types 2) By Application: Fluid And Electrolyte Imbalance, Nutritional Support, Medication Administration, Blood Transfusion, Other Applications 3) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, Other End-Users Subsegments: 1) By Crystalloids: Normal Saline (0.9% Sodium Chloride), Half Normal Saline (0.45% Sodium Chloride), Lactated Ringer’s Solution, Dextrose Solutions, Hypertonic Saline 2) By Colloids: Albumin, Dextran, Hydroxyethyl Starch (HES), Gelatin 3) By Blood Products: Packed Red Blood Cells (PRBCs), Platelets, Fresh Frozen Plasma (FFP), Cryoprecipitate 4) By Other Product Types: Intravenous Immunoglobulins (IVIG), Parenteral Nutrition Solutions, Specialty Intravenous Drugs And Additives

What Is The Driver Of The Intravenous Therapy Solutions Market?

The growing demand for minimally invasive therapies is expected to drive the growth of the intravenous therapy solutions market in the future. Minimally invasive therapies refer to medical treatments that involve minimal incisions or insertion into the body, often resulting in quicker recovery and reduced complications. The growing demand for minimally invasive therapies is due to their ability to reduce postoperative pain, which leads to faster patient recovery and improved overall comfort during the healing process. Intravenous therapy solutions support minimally invasive therapies by enabling the efficient delivery of essential fluids, medications, and nutrients directly into the bloodstream, ensuring optimal patient care and faster recovery. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, minimally invasive procedures increased by 7% in 2023, outpacing surgical procedures by 2%. Therefore, the growing demand for minimally invasive therapies is driving the growth of the intravenous (IV) therapy solutions market.

Key Players In The Global Intravenous Therapy Solutions Market

Major companies operating in the intravenous therapy solutions market are Pfizer Inc., Otsuka Pharmaceutical Co. Ltd., Baxter International Inc., Fresenius Kabi AG, Grifols S.A., Terumo Corporation, Dr. Reddy’s Laboratories Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Hikma Pharmaceuticals PLC, Biocon Limited, B. Braun Melsungen Aktiengesellschaft, JW Life Science Corporation, AdvaCare Pharma USA, Soxa Formulations & Research Pvt. Ltd., Vifor Pharma Management Ltd., Aetos Pharma Private Limited, LXIR Medilabs Private Limited, Amanta Healthcare Limited, Aculife Healthcare Private Limited, Claris Lifesciences Limited, Osel Lifesciences Pvt. Ltd., BBraun Avitum AG

Global Intravenous Therapy Solutions Market Trends and Insights

Major companies operating in the intravenous therapy solutions market are focusing on developing innovative solutions such as ready-to-use drug infusion to enhance treatment efficiency and reduce preparation time in clinical settings. Ready-to-use drug infusion refers to pre-mixed, pre-labeled intravenous (IV) medications that are prepared in standardized doses and packaging, eliminating the need for on-site compounding or dilution. For instance, in May 2024, B. Braun Medical Inc., a US-based manufacturing company, launched Levetiracetam in Sodium Chloride Injection, a ready-to-use intravenous anticonvulsant solution. This product is designed for the treatment of seizures and is available in standardized concentrations and volumes, eliminating the need for dilution or compounding at the point of care. The Levetiracetam IV formulation is pre-mixed in a flexible container, ensuring accuracy in dosing, reducing the risk of contamination, and enhancing convenience for healthcare professionals in emergency and inpatient settings.

What Are Latest Mergers And Acquisitions In The Intravenous Therapy Solutions Market?

In April 2025, Organon & Co., a US-based healthcare company, acquired the regulatory and commercial rights to Tofidence from Biogen Inc. With this acquisition, Organon & Co. aims to strengthen and expand its US biosimilars immunology portfolio by adding Tofidence to support treatment for multiple arthritis indications and COVID-19, while leveraging its commercial expertise and market access capabilities to drive long-term growth in the immunology segment. Biogen Inc. is a US-based biotechnology company that specializes in providing intravenous therapy solutions such as Tofidence.

Regional Outlook

North America was the largest region in the intravenous therapy solutions market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Intravenous Therapy Solutions Market?

The intravenous therapy solutions market consists of sales of saline solutions, dextrose solutions, lactated Ringer’s solutions, amino acid solutions, vitamin and mineral infusions, IV antibiotic solutions, chemotherapy IV solutions, and parenteral nutrition solutions. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.